Adipocyte - breast, donor1.CNhs11051.11376-118A8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte - breast, donor2.CNhs11969.11327-117E4 | 597.13 | 195.05 | 59.52 | 51.38 | 7.49 |
Adipocyte - omental, donor1.CNhs11054.11473-119C6 | 775.95 | 223.69 | 53.99 | 35.80 | 5.64 |
Adipocyte - omental, donor2.CNhs12067.11474-119C7 | 310.23 | 173.13 | 54.04 | 26.02 | 11.01 |
Adipocyte - omental, donor3.CNhs12068.11475-119C8 | 431.76 | 221.25 | 47.38 | 45.14 | 3.13 |
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9 | 384.70 | 207.62 | 67.17 | 34.02 | 16.57 |
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8 | 412.88 | 91.19 | 35.46 | 35.46 | 0.00 |
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4 | 288.06 | 105.50 | 37.27 | 13.27 | 2.53 |
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4 | 564.94 | 143.65 | 62.68 | 19.07 | 2.09 |
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7 | 60.70 | 50.38 | 22.12 | 1.97 | 0.74 |
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6 | 34.19 | 36.29 | 20.24 | 0.70 | 0.00 |
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3 | 102.01 | 77.77 | 35.82 | 4.37 | 1.53 |
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2 | 125.82 | 65.68 | 42.20 | 4.22 | 1.32 |
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6 | 188.99 | 104.46 | 52.11 | 5.57 | 1.61 |
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5 | 115.66 | 116.32 | 50.04 | 8.28 | 1.33 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5 | 289.10 | 116.98 | 49.08 | 16.14 | 1.34 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4 | 309.78 | 131.39 | 57.26 | 22.90 | 7.23 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6 | 353.47 | 138.03 | 46.01 | 16.80 | 2.19 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5 | 368.88 | 139.55 | 63.92 | 18.05 | 3.42 |
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6 | 69.07 | 94.31 | 34.84 | 4.56 | 0.98 |
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5 | 62.83 | 58.14 | 34.48 | 2.86 | 0.20 |
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5 | 211.90 | 89.02 | 61.75 | 5.64 | 1.57 |
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2 | 177.18 | 83.01 | 51.24 | 7.73 | 0.57 |
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2 | 129.07 | 63.92 | 39.83 | 3.56 | 0.82 |
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6 | 140.11 | 57.88 | 45.20 | 3.39 | 0.75 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2 | 3.90 | 3.97 | 3.29 | 0.23 | 0.00 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3 | 3.37 | 3.53 | 2.46 | 0.16 | 0.00 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4 | 1.89 | 4.80 | 2.20 | 0.08 | 0.08 |
Basophils, donor1.CNhs12546.12241-129G9 | 600.27 | 223.82 | 63.73 | 29.90 | 3.15 |
Basophils, donor2.CNhs12563.12242-129H1 | 305.53 | 140.87 | 58.34 | 9.21 | 3.07 |
Basophils, donor3.CNhs12575.12243-129H2 | 587.68 | 162.87 | 72.45 | 18.42 | 2.17 |
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4 | 60.68 | 50.57 | 22.07 | 2.76 | 0.92 |
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8 | 105.42 | 60.84 | 25.60 | 6.93 | 0.60 |
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3 | 82.82 | 63.60 | 22.92 | 8.50 | 0.37 |
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8 | 10.15 | 10.30 | 5.73 | 0.08 | 0.15 |
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8 | 9.81 | 13.65 | 9.81 | 0.28 | 0.14 |
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1 | 159.72 | 93.07 | 44.33 | 4.40 | 0.29 |
CD14+ Monocytes, donor1.CNhs10852.11224-116B9 | 525.19 | 138.50 | 40.44 | 19.39 | 0.55 |
CD14+ Monocytes, donor2.CNhs11954.11305-117B9 | 602.23 | 178.08 | 69.99 | 24.87 | 1.80 |
CD14+ Monocytes, donor3.CNhs11997.11381-118B4 | 700.08 | 159.07 | 69.88 | 16.28 | 2.17 |
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5 | 1098.53 | 276.31 | 69.86 | 38.74 | 6.49 |
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5 | 1041.97 | 378.31 | 68.67 | 53.77 | 6.48 |
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9 | 1116.07 | 361.38 | 79.33 | 53.06 | 4.64 |
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9 | 844.18 | 171.86 | 61.50 | 39.26 | 6.11 |
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1 | 587.60 | 167.40 | 64.24 | 26.07 | 5.29 |
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2 | 645.76 | 159.86 | 61.62 | 35.66 | 5.34 |
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6 | 873.70 | 194.31 | 50.90 | 40.21 | 7.67 |
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7 | 601.54 | 159.94 | 57.56 | 29.60 | 4.52 |
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8 | 534.55 | 146.18 | 41.50 | 29.42 | 3.41 |
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6 | 1123.44 | 228.72 | 61.85 | 52.36 | 10.07 |
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7 | 793.84 | 189.56 | 62.50 | 34.58 | 4.61 |
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8 | 803.09 | 213.78 | 51.79 | 49.42 | 6.86 |
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5 | 1037.68 | 243.39 | 69.98 | 43.78 | 7.24 |
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6 | 675.18 | 193.00 | 58.74 | 38.08 | 1.94 |
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7 | 710.99 | 196.37 | 65.00 | 33.86 | 4.06 |
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4 | 840.88 | 195.96 | 62.31 | 41.41 | 9.41 |
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5 | 561.10 | 151.19 | 50.76 | 40.66 | 3.00 |
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6 | 602.26 | 149.67 | 46.97 | 31.91 | 7.64 |
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1 | 1007.63 | 232.32 | 66.42 | 47.14 | 7.96 |
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2 | 733.32 | 215.66 | 53.27 | 40.44 | 3.21 |
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3 | 693.04 | 193.08 | 62.66 | 33.25 | 9.59 |
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7 | 933.48 | 215.06 | 57.06 | 49.81 | 8.91 |
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8 | 840.14 | 191.09 | 62.43 | 46.67 | 9.18 |
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9 | 675.57 | 193.51 | 50.72 | 43.47 | 6.82 |
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3 | 1079.00 | 255.67 | 81.26 | 55.72 | 6.67 |
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4 | 741.57 | 201.42 | 62.41 | 34.04 | 4.54 |
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5 | 663.31 | 176.26 | 33.63 | 33.63 | 4.98 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8 | 1016.55 | 218.59 | 71.10 | 42.46 | 10.05 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9 | 774.40 | 186.17 | 67.27 | 38.59 | 5.21 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1 | 756.03 | 195.69 | 56.69 | 37.14 | 8.25 |
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2 | 975.90 | 252.45 | 56.30 | 51.46 | 9.08 |
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3 | 778.17 | 257.06 | 68.87 | 37.20 | 4.05 |
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4 | 767.10 | 205.38 | 52.22 | 36.39 | 7.60 |
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7 | 644.12 | 210.20 | 56.41 | 27.46 | 7.18 |
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1 | 572.97 | 149.25 | 43.80 | 23.17 | 5.10 |
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4 | 829.20 | 260.82 | 64.78 | 35.22 | 4.61 |
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6 | 757.54 | 195.90 | 59.76 | 28.53 | 4.38 |
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8 | 683.46 | 181.11 | 55.42 | 28.23 | 4.05 |
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2 | 758.46 | 251.70 | 71.04 | 28.77 | 1.13 |
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8 | 609.07 | 146.78 | 45.32 | 27.93 | 5.99 |
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9 | 629.17 | 163.91 | 53.91 | 31.43 | 5.97 |
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3 | 761.53 | 217.74 | 57.90 | 35.25 | 3.65 |
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2 | 114.40 | 139.04 | 68.64 | 1.76 | 1.76 |
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7 | 162.20 | 141.45 | 57.34 | 2.73 | 3.28 |
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3 | 134.32 | 125.42 | 73.83 | 4.45 | 2.67 |
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9 | 134.42 | 97.72 | 44.81 | 2.56 | 1.71 |
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5 | 116.92 | 111.71 | 46.85 | 1.60 | 0.40 |
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8 | 166.68 | 125.87 | 65.52 | 1.72 | 2.30 |
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4 | 154.68 | 144.77 | 60.82 | 2.64 | 0.66 |
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9 | 144.06 | 117.35 | 49.61 | 0.95 | 1.91 |
CD19+ B Cells, donor1.CNhs12343.11544-120B5 | 166.21 | 124.66 | 71.15 | 5.12 | 2.28 |
CD19+ B Cells, donor2.CNhs12352.11624-122B4 | 131.54 | 87.50 | 73.40 | 2.94 | 2.35 |
CD19+ B Cells, donor3.CNhs12354.11705-123B4 | 121.18 | 82.19 | 76.84 | 3.06 | 0.38 |
CD34+ Progenitors, donor1.CNhs13227.11545-120B6 | 219.40 | 85.91 | 55.51 | 7.93 | 2.64 |
CD34+ Progenitors, donor2.CNhs12205.11625-122B5 | 108.18 | 82.39 | 37.55 | 11.77 | 2.24 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2 | 119.84 | 75.33 | 44.51 | 2.63 | 1.05 |
CD4+ T Cells, donor1.CNhs10853.11225-116C1 | 338.54 | 158.35 | 75.14 | 9.25 | 1.38 |
CD4+ T Cells, donor2.CNhs11955.11306-117C1 | 254.28 | 147.38 | 74.67 | 6.29 | 1.97 |
CD4+ T Cells, donor3.CNhs11998.11382-118B5 | 347.06 | 170.24 | 94.17 | 6.78 | 2.67 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2 | 176.72 | 134.59 | 71.72 | 3.68 | 1.34 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7 | 280.62 | 184.15 | 92.24 | 7.17 | 2.93 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5 | 272.71 | 189.38 | 96.11 | 8.52 | 4.26 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8 | 270.81 | 231.84 | 120.79 | 9.74 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3 | 166.89 | 130.24 | 84.00 | 5.46 | 2.56 |
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9 | 243.93 | 192.97 | 113.72 | 5.89 | 3.83 |
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6 | 250.78 | 199.16 | 117.41 | 5.10 | 5.32 |
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9 | 173.04 | 170.06 | 95.32 | 7.85 | 2.98 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8 | 184.71 | 114.26 | 76.73 | 5.00 | 3.71 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3 | 177.27 | 116.27 | 74.39 | 4.94 | 4.42 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5 | 281.19 | 129.25 | 70.87 | 7.40 | 6.08 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9 | 223.57 | 133.20 | 65.22 | 3.87 | 4.97 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9 | 206.34 | 164.32 | 58.25 | 10.43 | 4.64 |
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2 | 352.63 | 184.62 | 77.70 | 9.05 | 3.41 |
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4 | 323.99 | 190.76 | 88.56 | 5.08 | 2.94 |
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7 | 313.61 | 242.52 | 85.72 | 8.36 | 5.23 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1 | 161.01 | 105.26 | 63.57 | 3.51 | 1.93 |
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4 | 331.49 | 159.04 | 81.63 | 7.66 | 3.45 |
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7 | 302.05 | 173.19 | 87.28 | 6.53 | 1.03 |
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1 | 338.54 | 210.51 | 82.23 | 7.34 | 2.78 |
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8 | 328.76 | 215.99 | 101.94 | 7.33 | 2.23 |
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4 | 271.50 | 203.14 | 103.52 | 7.16 | 1.95 |
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9 | 333.61 | 245.22 | 103.60 | 6.65 | 3.80 |
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6 | 162.02 | 196.95 | 69.42 | 8.58 | 1.51 |
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2 | 162.93 | 189.04 | 82.81 | 6.02 | 0.90 |
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5 | 291.09 | 229.87 | 59.97 | 12.49 | 2.50 |
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1 | 372.69 | 210.26 | 94.47 | 10.42 | 1.18 |
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6 | 315.31 | 192.97 | 105.93 | 5.75 | 0.82 |
CD8+ T Cells, donor1.CNhs10854.11226-116C2 | 206.24 | 120.56 | 80.04 | 5.64 | 1.81 |
CD8+ T Cells, donor2.CNhs11956.11307-117C2 | 186.14 | 115.27 | 73.28 | 6.42 | 3.21 |
CD8+ T Cells, donor3.CNhs11999.11383-118B6 | 276.90 | 114.70 | 94.28 | 5.21 | 1.74 |
Cardiac Myocyte, donor1.CNhs12341.11525-119I4 | 1336.06 | 316.95 | 58.51 | 39.01 | 19.50 |
Cardiac Myocyte, donor2.CNhs12350.11605-120I3 | 543.94 | 145.54 | 50.30 | 19.45 | 0.67 |
Cardiac Myocyte, donor3.CNhs12571.11686-122I3 | 346.12 | 124.41 | 64.44 | 12.40 | 1.53 |
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1 | 133.37 | 101.20 | 32.53 | 6.51 | 5.78 |
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6 | 246.66 | 125.33 | 55.15 | 14.04 | 1.50 |
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6 | 704.97 | 198.87 | 85.60 | 22.02 | 3.48 |
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7 | 282.33 | 158.26 | 66.80 | 10.34 | 0.80 |
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7 | 685.67 | 220.93 | 125.07 | 20.93 | 8.27 |
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9 | 162.51 | 75.34 | 42.73 | 3.12 | 1.61 |
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9 | 177.83 | 73.17 | 36.81 | 4.88 | 0.89 |
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4 | 208.17 | 77.47 | 48.05 | 5.27 | 1.05 |
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1 | 802.77 | 242.11 | 61.56 | 38.77 | 2.29 |
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5 | 284.15 | 172.31 | 64.84 | 17.85 | 0.00 |
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4 | 352.62 | 123.84 | 46.72 | 18.91 | 1.11 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3 | 267.10 | 82.76 | 41.22 | 15.58 | 2.27 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3 | 282.44 | 86.72 | 31.00 | 16.37 | 2.61 |
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7 | 337.05 | 82.83 | 43.48 | 14.09 | 1.99 |
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4 | 164.08 | 66.06 | 48.89 | 4.29 | 1.43 |
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4 | 185.33 | 81.22 | 63.49 | 4.00 | 1.14 |
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8 | 69.46 | 63.52 | 35.29 | 5.20 | 0.74 |
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1 | 145.69 | 50.09 | 26.24 | 5.37 | 0.20 |
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3 | 261.51 | 79.14 | 30.97 | 7.74 | 0.86 |
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8 | 172.88 | 82.62 | 32.98 | 7.29 | 0.69 |
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8 | 295.09 | 105.71 | 27.70 | 10.74 | 0.57 |
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4 | 277.29 | 97.74 | 42.79 | 12.58 | 1.26 |
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9 | 194.51 | 60.25 | 27.24 | 11.00 | 0.55 |
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9 | 145.25 | 49.95 | 26.96 | 2.09 | 0.00 |
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3 | 395.64 | 127.40 | 34.89 | 17.83 | 3.10 |
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3 | 487.40 | 160.45 | 47.32 | 22.41 | 0.71 |
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7 | 371.54 | 194.14 | 54.22 | 22.09 | 0.33 |
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5 | 135.35 | 99.90 | 36.66 | 12.89 | 4.43 |
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1 | 431.83 | 143.69 | 21.29 | 38.01 | 6.84 |
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1 | 474.21 | 130.57 | 67.85 | 12.20 | 0.73 |
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6 | 100.74 | 85.67 | 26.84 | 11.40 | 1.47 |
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2 | 221.98 | 98.03 | 34.84 | 8.10 | 0.00 |
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1 | 175.38 | 67.78 | 29.65 | 5.18 | 1.16 |
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1 | 192.42 | 68.48 | 41.09 | 3.59 | 0.22 |
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5 | 199.77 | 72.30 | 38.51 | 4.62 | 0.68 |
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7 | 95.06 | 52.13 | 18.40 | 7.67 | 0.00 |
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3 | 132.90 | 74.99 | 26.58 | 0.95 | 0.00 |
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3 | 152.79 | 57.16 | 26.20 | 4.95 | 0.37 |
Eosinophils, donor2.CNhs12548.12245-129H4 | 3364.35 | 915.87 | 117.28 | 213.48 | 13.18 |
Eosinophils, donor3.CNhs12549.12246-129H5 | 4955.83 | 1085.78 | 174.50 | 271.45 | 15.51 |
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4 | 295.67 | 162.23 | 74.57 | 10.03 | 0.44 |
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3 | 525.80 | 153.07 | 73.05 | 16.90 | 7.45 |
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3 | 304.93 | 93.45 | 38.50 | 10.64 | 3.17 |
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3 | 404.11 | 147.37 | 43.43 | 18.40 | 2.12 |
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9 | 620.71 | 345.06 | 135.67 | 32.13 | 5.74 |
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6 | 280.90 | 97.89 | 61.71 | 8.16 | 1.42 |
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8 | 266.32 | 90.27 | 48.78 | 13.46 | 2.24 |
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4 | 171.87 | 71.52 | 28.82 | 3.20 | 2.13 |
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4 | 419.33 | 118.40 | 61.42 | 8.88 | 1.48 |
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3 | 563.91 | 183.61 | 58.51 | 19.92 | 1.56 |
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7 | 179.70 | 91.60 | 37.45 | 11.18 | 1.89 |
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2 | 169.35 | 84.18 | 35.96 | 13.57 | 1.31 |
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7 | 184.50 | 151.96 | 36.78 | 12.41 | 1.51 |
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6 | 464.40 | 131.94 | 54.16 | 10.95 | 1.73 |
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1 | 57.88 | 49.91 | 30.93 | 1.17 | 0.00 |
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9 | 96.77 | 72.73 | 37.46 | 4.06 | 0.94 |
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5 | 90.13 | 46.78 | 17.68 | 2.85 | 0.57 |
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5 | 122.70 | 64.11 | 39.60 | 3.89 | 0.45 |
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1 | 25.13 | 30.42 | 18.08 | 1.17 | 0.23 |
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5 | 23.63 | 22.99 | 17.81 | 1.78 | 0.00 |
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9 | 22.05 | 24.58 | 18.12 | 1.83 | 0.14 |
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4 | 94.12 | 51.24 | 27.56 | 3.88 | 0.61 |
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4 | 60.80 | 35.87 | 23.22 | 1.60 | 0.61 |
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8 | 166.56 | 73.46 | 49.60 | 4.44 | 0.31 |
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7 | 402.73 | 119.99 | 78.41 | 9.50 | 1.19 |
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7 | 406.01 | 131.79 | 77.64 | 10.39 | 2.72 |
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3 | 72.81 | 140.16 | 31.86 | 3.64 | 0.00 |
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2 | 175.34 | 112.10 | 53.90 | 6.47 | 0.00 |
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5 | 65.15 | 41.24 | 22.22 | 1.85 | 0.51 |
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5 | 66.06 | 43.54 | 24.90 | 2.13 | 0.25 |
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9 | 83.40 | 58.74 | 29.65 | 2.49 | 0.00 |
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8 | 183.93 | 99.21 | 64.97 | 7.46 | 0.88 |
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8 | 231.70 | 85.51 | 47.20 | 7.97 | 1.53 |
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3 | 479.71 | 149.19 | 94.50 | 10.82 | 1.35 |
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8 | 348.80 | 93.69 | 32.56 | 15.43 | 3.52 |
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9 | 107.99 | 108.71 | 51.66 | 4.66 | 0.54 |
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8 | 268.01 | 153.12 | 61.93 | 14.74 | 1.71 |
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9 | 193.92 | 115.93 | 40.48 | 5.93 | 1.27 |
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6 | 192.36 | 145.54 | 60.62 | 6.00 | 2.10 |
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3 | 88.52 | 93.47 | 37.41 | 5.67 | 1.24 |
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3 | 107.44 | 124.96 | 42.77 | 10.05 | 1.29 |
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5 | 234.51 | 164.53 | 49.32 | 12.84 | 2.05 |
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9 | 335.70 | 158.48 | 59.75 | 10.97 | 2.03 |
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4 | 96.66 | 100.17 | 39.17 | 8.67 | 1.36 |
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6 | 69.17 | 81.03 | 32.56 | 4.29 | 1.01 |
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7 | 232.33 | 117.18 | 44.92 | 7.00 | 1.66 |
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1 | 153.73 | 150.49 | 45.10 | 9.54 | 1.45 |
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3 | 326.61 | 226.14 | 113.25 | 13.85 | 3.20 |
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2 | 70.53 | 75.06 | 39.29 | 5.74 | 0.81 |
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6 | 76.13 | 64.77 | 27.81 | 3.22 | 1.19 |
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6 | 364.68 | 133.54 | 39.81 | 14.11 | 2.51 |
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6 | 387.30 | 162.56 | 36.82 | 18.82 | 3.00 |
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2 | 328.39 | 135.95 | 51.34 | 13.48 | 2.58 |
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6 | 89.28 | 42.93 | 29.52 | 3.42 | 0.73 |
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5 | 86.01 | 37.37 | 27.70 | 4.90 | 0.66 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8 | 111.66 | 57.05 | 33.46 | 4.88 | 0.81 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7 | 148.03 | 68.83 | 37.84 | 8.60 | 1.66 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6 | 176.88 | 68.88 | 39.87 | 4.79 | 0.50 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9 | 48.18 | 33.94 | 22.99 | 1.46 | 1.46 |
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2 | 233.11 | 82.92 | 57.89 | 9.39 | 0.00 |
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7 | 310.04 | 123.50 | 59.82 | 4.50 | 4.50 |
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7 | 99.46 | 46.97 | 30.39 | 5.53 | 0.00 |
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1 | 286.52 | 109.59 | 54.33 | 6.97 | 0.93 |
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9 | 253.38 | 112.61 | 57.03 | 4.33 | 1.44 |
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8 | 71.10 | 35.37 | 17.04 | 3.90 | 0.59 |
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9 | 78.73 | 37.26 | 16.35 | 4.05 | 0.34 |
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1 | 64.59 | 41.45 | 19.04 | 3.86 | 0.48 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9 | 81.29 | 34.74 | 17.65 | 3.09 | 0.55 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1 | 63.84 | 40.09 | 17.21 | 3.27 | 0.22 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2 | 71.18 | 42.23 | 19.22 | 2.85 | 0.47 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4 | 92.36 | 38.97 | 17.93 | 3.78 | 0.67 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5 | 69.07 | 38.66 | 18.64 | 3.73 | 1.18 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6 | 89.65 | 37.32 | 16.93 | 6.16 | 0.38 |
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9 | 244.33 | 161.66 | 61.27 | 16.24 | 1.48 |
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8 | 224.39 | 65.91 | 64.51 | 8.41 | 0.00 |
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3 | 125.53 | 88.08 | 40.75 | 5.76 | 0.82 |
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2 | 157.30 | 80.85 | 45.57 | 1.47 | 0.00 |
Hepatocyte, donor1.CNhs12340.11523-119I2 | 476.60 | 109.01 | 41.83 | 16.48 | 8.87 |
Hepatocyte, donor2.CNhs12349.11603-120I1 | 395.10 | 110.08 | 27.52 | 13.76 | 3.93 |
Hepatocyte, donor3.CNhs12626.11684-122I1 | 408.24 | 134.70 | 44.31 | 11.23 | 2.36 |
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3 | 110.81 | 68.43 | 32.23 | 2.65 | 0.88 |
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4 | 159.76 | 74.41 | 20.29 | 7.26 | 0.98 |
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9 | 314.14 | 121.30 | 63.82 | 6.69 | 1.03 |
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3 | 271.63 | 108.54 | 25.35 | 11.96 | 2.85 |
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8 | 145.00 | 61.82 | 17.98 | 6.74 | 1.12 |
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8 | 198.04 | 66.15 | 29.96 | 4.72 | 0.70 |
Keratinocyte - oral, donor1.CNhs10879.11251-116E9 | 360.08 | 151.20 | 52.78 | 10.00 | 2.41 |
Keratocytes, donor1.CNhs11337.11527-119I6 | 38.12 | 38.12 | 15.96 | 0.98 | 0.33 |
Keratocytes, donor2.CNhs12095.11607-120I5 | 96.71 | 50.96 | 22.88 | 3.12 | 1.04 |
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8 | 170.31 | 73.61 | 38.97 | 7.22 | 0.00 |
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7 | 188.97 | 115.35 | 74.78 | 4.64 | 0.35 |
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7 | 699.99 | 219.79 | 85.12 | 29.59 | 0.82 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1 | 292.63 | 115.06 | 39.70 | 8.95 | 2.45 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6 | 288.44 | 117.14 | 40.28 | 8.33 | 1.39 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2 | 400.48 | 115.10 | 44.90 | 16.74 | 3.81 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1 | 120.11 | 57.68 | 17.38 | 6.32 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4 | 123.62 | 57.52 | 21.46 | 4.29 | 0.00 |
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8 | 1529.01 | 347.41 | 74.60 | 93.07 | 9.85 |
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8 | 318.25 | 124.02 | 53.82 | 20.83 | 1.64 |
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3 | 737.95 | 190.10 | 63.61 | 37.90 | 2.08 |
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9 | 383.37 | 171.53 | 41.24 | 18.75 | 2.81 |
Mallassez-derived cells, donor2.CNhs13550.11929-125I3 | 338.82 | 147.99 | 53.92 | 21.33 | 2.02 |
Mallassez-derived cells, donor3.CNhs13551.11930-125I4 | 257.46 | 117.25 | 36.58 | 13.61 | 0.99 |
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4 | 220.76 | 70.57 | 22.39 | 7.52 | 0.63 |
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9 | 180.77 | 76.44 | 29.64 | 8.43 | 1.16 |
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9 | 189.77 | 52.91 | 30.29 | 4.60 | 0.77 |
Mast cell - stimulated, donor1.CNhs11073.11487-119E2 | 1592.29 | 480.35 | 102.47 | 164.55 | 0.00 |
Mast cell, donor1.CNhs12566.11563-120D6 | 1248.97 | 342.68 | 116.14 | 51.24 | 4.58 |
Mast cell, donor2.CNhs12594.11565-120D8 | 1177.42 | 447.00 | 153.84 | 44.99 | 2.70 |
Mast cell, donor3.CNhs12593.11566-120D9 | 947.16 | 426.45 | 161.70 | 40.50 | 5.62 |
Mast cell, donor4.CNhs12592.11567-120E1 | 1098.31 | 456.49 | 159.95 | 43.68 | 1.89 |
Melanocyte - dark, donor3.CNhs12570.11663-122F7 | 229.86 | 91.31 | 38.04 | 18.54 | 0.63 |
Melanocyte - light, donor1.CNhs11303.11274-116H5 | 190.61 | 77.54 | 37.82 | 9.55 | 0.00 |
Melanocyte - light, donor2.CNhs11383.11351-117H1 | 148.87 | 77.36 | 21.10 | 15.24 | 3.52 |
Melanocyte - light, donor3.CNhs12033.11423-118G1 | 248.06 | 58.16 | 44.48 | 8.55 | 1.71 |
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4 | 158.77 | 55.94 | 35.58 | 5.45 | 1.13 |
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3 | 261.90 | 94.61 | 29.43 | 20.12 | 3.00 |
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2 | 339.56 | 109.19 | 41.16 | 12.29 | 1.71 |
Meningeal Cells, donor1.CNhs11320.11493-119E8 | 40.03 | 63.58 | 23.66 | 2.35 | 0.22 |
Meningeal Cells, donor2.CNhs12080.11573-120E7 | 96.35 | 82.83 | 42.72 | 2.62 | 0.44 |
Meningeal Cells, donor3.CNhs12731.11654-122E7 | 94.90 | 57.28 | 23.69 | 3.45 | 0.29 |
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9 | 331.32 | 110.92 | 41.37 | 14.48 | 1.94 |
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7 | 207.44 | 121.60 | 32.19 | 7.15 | 0.00 |
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6 | 142.01 | 67.62 | 31.28 | 2.54 | 0.00 |
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8 | 428.96 | 162.75 | 53.99 | 19.15 | 4.52 |
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7 | 380.67 | 104.01 | 49.92 | 17.68 | 1.04 |
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6 | 54.01 | 52.47 | 25.46 | 3.60 | 0.26 |
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5 | 68.09 | 29.79 | 18.44 | 1.42 | 1.42 |
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5 | 56.48 | 40.76 | 24.51 | 1.86 | 0.53 |
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7 | 246.92 | 142.55 | 48.47 | 8.15 | 0.71 |
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9 | 259.37 | 129.69 | 39.61 | 5.43 | 1.63 |
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8 | 93.03 | 54.33 | 26.34 | 4.94 | 0.00 |
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2 | 104.56 | 47.88 | 24.43 | 1.30 | 0.00 |
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3 | 219.99 | 105.20 | 46.91 | 6.04 | 0.71 |
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8 | 88.70 | 49.89 | 24.55 | 4.75 | 0.79 |
Mesothelial Cells, donor1.CNhs10850.11247-116E5 | 435.88 | 157.05 | 59.08 | 19.89 | 3.01 |
Mesothelial Cells, donor2.CNhs12197.12156-128G5 | 670.21 | 197.84 | 55.78 | 28.76 | 5.23 |
Mesothelial Cells, donor3.CNhs12012.11402-118D7 | 457.08 | 144.66 | 67.28 | 15.40 | 2.10 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5 | 1472.86 | 290.68 | 80.27 | 54.73 | 23.11 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2 | 1471.11 | 301.86 | 71.32 | 63.79 | 15.07 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8 | 912.91 | 183.43 | 86.44 | 40.06 | 56.93 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1 | 149.29 | 86.50 | 40.74 | 8.63 | 0.72 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9 | 227.43 | 106.82 | 51.69 | 5.74 | 1.15 |
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4 | 179.72 | 74.17 | 51.35 | 2.85 | 0.00 |
Myoblast, donor1.CNhs10870.11241-116D8 | 203.42 | 57.91 | 30.98 | 8.25 | 1.88 |
Myoblast, donor2.CNhs11965.11322-117D8 | 200.34 | 80.75 | 40.68 | 5.55 | 1.23 |
Myoblast, donor3.CNhs11908.11398-118D3 | 187.83 | 104.93 | 51.21 | 12.53 | 2.15 |
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3 | 95.38 | 49.88 | 37.66 | 2.24 | 0.45 |
Natural Killer Cells, donor1.CNhs10859.11230-116C6 | 202.55 | 103.84 | 63.25 | 5.12 | 1.18 |
Natural Killer Cells, donor2.CNhs11957.11311-117C6 | 206.57 | 117.30 | 87.76 | 3.88 | 3.02 |
Natural Killer Cells, donor3.CNhs12001.11387-118C1 | 260.54 | 115.89 | 92.15 | 5.26 | 1.28 |
Neural stem cells, donor1.CNhs11063.11275-116H6 | 272.64 | 126.29 | 44.21 | 9.66 | 0.76 |
Neural stem cells, donor2.CNhs11384.11352-117H2 | 167.88 | 111.92 | 59.86 | 2.60 | 1.30 |
Neurons, donor1.CNhs12338.11494-119E9 | 125.27 | 68.82 | 47.17 | 6.19 | 1.55 |
Neurons, donor2.CNhs12726.11574-120E8 | 122.96 | 71.36 | 39.37 | 4.19 | 1.01 |
Neurons, donor3.CNhs13815.11655-122E8 | 143.54 | 46.57 | 35.09 | 4.47 | 3.83 |
Neutrophils, donor1.CNhs10862.11233-116C9 | 6276.68 | 1132.50 | 134.82 | 253.91 | 74.15 |
Neutrophils, donor2.CNhs11959.11314-117C9 | 5734.93 | 1130.83 | 152.57 | 206.42 | 149.58 |
Neutrophils, donor3.CNhs11905.11390-118C4 | 6108.48 | 1467.03 | 155.82 | 345.21 | 18.65 |
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1 | 246.61 | 131.28 | 67.73 | 6.01 | 1.47 |
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5 | 312.61 | 132.05 | 73.02 | 7.00 | 2.50 |
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4 | 99.01 | 89.25 | 42.05 | 4.88 | 1.09 |
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7 | 326.72 | 101.91 | 55.94 | 7.90 | 5.82 |
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8 | 217.50 | 65.66 | 39.25 | 6.96 | 2.14 |
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9 | 280.87 | 88.47 | 45.42 | 5.99 | 3.63 |
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1 | 482.04 | 146.54 | 66.30 | 12.07 | 4.57 |
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7 | 267.24 | 111.05 | 43.34 | 10.53 | 1.81 |
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3 | 445.72 | 147.81 | 63.67 | 31.84 | 0.00 |
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3 | 221.43 | 88.99 | 49.67 | 9.31 | 1.03 |
Osteoblast, donor2.CNhs11385.11354-117H4 | 98.31 | 67.09 | 32.55 | 2.66 | 0.66 |
Osteoblast, donor3.CNhs12036.11426-118G4 | 121.50 | 45.72 | 29.31 | 5.16 | 0.18 |
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7 | 162.04 | 69.94 | 35.62 | 4.69 | 1.91 |
Pericytes, donor1.CNhs11317.11491-119E6 | 127.86 | 129.03 | 52.47 | 7.44 | 1.37 |
Pericytes, donor2.CNhs12079.11571-120E5 | 150.30 | 117.70 | 57.30 | 11.67 | 0.34 |
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7 | 335.58 | 148.46 | 60.58 | 16.95 | 1.65 |
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7 | 555.46 | 158.33 | 61.69 | 20.71 | 1.94 |
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2 | 503.43 | 164.04 | 76.95 | 11.31 | 2.13 |
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9 | 53.96 | 29.40 | 10.61 | 1.52 | 0.00 |
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5 | 99.86 | 68.24 | 48.27 | 4.99 | 1.66 |
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5 | 114.00 | 58.36 | 35.98 | 1.81 | 0.91 |
Preadipocyte - breast, donor1.CNhs11052.11467-119B9 | 459.50 | 188.81 | 56.32 | 20.59 | 5.21 |
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9 | 548.17 | 192.44 | 71.97 | 16.42 | 2.76 |
Preadipocyte - breast, donor2.CNhs11971.11328-117E5 | 331.74 | 120.12 | 55.57 | 11.79 | 4.49 |
Preadipocyte - omental, donor1.CNhs11065.11468-119C1 | 631.85 | 244.87 | 63.69 | 26.14 | 8.07 |
Preadipocyte - omental, donor2.CNhs11902.11329-117E6 | 550.09 | 217.48 | 57.31 | 26.61 | 6.65 |
Preadipocyte - omental, donor3.CNhs12013.11403-118D8 | 673.50 | 177.26 | 71.74 | 17.53 | 3.70 |
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2 | 280.51 | 192.94 | 53.43 | 19.29 | 2.97 |
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6 | 107.79 | 53.20 | 22.82 | 2.78 | 0.62 |
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6 | 334.53 | 95.17 | 59.13 | 9.23 | 1.95 |
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2 | 133.79 | 71.20 | 29.40 | 4.60 | 0.99 |
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7 | 284.03 | 124.10 | 46.73 | 8.83 | 1.04 |
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7 | 97.97 | 65.08 | 31.84 | 5.11 | 1.39 |
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2 | 126.18 | 53.18 | 20.18 | 5.56 | 1.09 |
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8 | 617.16 | 205.52 | 61.76 | 38.70 | 3.41 |
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9 | 236.10 | 70.81 | 30.02 | 6.72 | 1.10 |
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3 | 191.97 | 62.92 | 26.41 | 4.48 | 1.84 |
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9 | 162.97 | 66.46 | 28.41 | 4.19 | 1.27 |
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1 | 367.80 | 120.77 | 63.46 | 11.93 | 1.84 |
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4 | 173.26 | 106.03 | 54.14 | 7.22 | 0.90 |
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3 | 223.88 | 129.15 | 55.37 | 9.63 | 1.31 |
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5 | 127.85 | 94.12 | 44.71 | 2.35 | 0.00 |
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4 | 255.74 | 90.61 | 33.61 | 16.08 | 1.46 |
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4 | 378.30 | 172.68 | 54.78 | 14.46 | 1.27 |
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2 | 139.89 | 95.54 | 53.45 | 11.37 | 0.00 |
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1 | 79.94 | 62.93 | 29.26 | 3.57 | 0.85 |
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1 | 203.82 | 83.78 | 34.98 | 6.69 | 2.38 |
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1 | 376.31 | 132.64 | 58.61 | 6.17 | 0.00 |
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6 | 171.51 | 107.02 | 46.06 | 8.94 | 0.00 |
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5 | 290.98 | 112.88 | 78.26 | 12.04 | 0.50 |
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3 | 235.25 | 155.98 | 57.86 | 12.23 | 1.53 |
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2 | 275.09 | 100.56 | 67.32 | 7.48 | 0.00 |
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2 | 204.85 | 86.19 | 44.77 | 6.04 | 0.90 |
Reticulocytes, biol_rep1.CNhs13552.11931-125I5 | 139.23 | 94.06 | 29.60 | 4.60 | 0.22 |
Reticulocytes, biol_rep2.CNhs13553.11932-125I6 | 142.48 | 104.05 | 34.77 | 3.14 | 1.31 |
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9 | 166.95 | 91.04 | 41.29 | 5.13 | 1.03 |
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7 | 222.07 | 129.24 | 57.40 | 11.81 | 0.00 |
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6 | 238.50 | 149.02 | 33.84 | 8.79 | 0.65 |
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5 | 622.37 | 234.01 | 51.83 | 35.34 | 2.68 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6 | 194.77 | 84.52 | 52.01 | 5.68 | 1.10 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5 | 182.10 | 109.33 | 49.75 | 5.61 | 0.50 |
Sebocyte, donor1.CNhs10847.11220-116B5 | 391.65 | 122.89 | 49.39 | 22.97 | 0.00 |
Sebocyte, donor2.CNhs11951.11301-117B5 | 454.39 | 122.86 | 40.30 | 20.80 | 0.65 |
Sertoli Cells, donor1.CNhs10851.11255-116F4 | 560.79 | 143.01 | 75.52 | 20.89 | 4.82 |
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3 | 90.77 | 54.62 | 27.36 | 2.51 | 0.39 |
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2 | 46.06 | 45.14 | 25.11 | 2.46 | 0.62 |
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6 | 53.57 | 49.58 | 21.95 | 2.76 | 0.61 |
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1 | 30.60 | 31.01 | 19.30 | 2.34 | 0.28 |
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7 | 118.27 | 64.56 | 26.75 | 3.01 | 1.07 |
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7 | 95.71 | 62.21 | 34.22 | 3.34 | 0.73 |
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2 | 95.45 | 46.11 | 26.76 | 2.39 | 0.68 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4 | 197.21 | 79.77 | 25.11 | 7.57 | 0.62 |
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5 | 334.04 | 118.34 | 28.59 | 17.35 | 3.47 |
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2 | 321.92 | 104.36 | 50.55 | 13.65 | 0.58 |
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6 | 174.32 | 77.08 | 23.35 | 5.74 | 2.04 |
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2 | 432.45 | 127.26 | 54.12 | 17.20 | 1.32 |
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2 | 75.77 | 30.21 | 24.17 | 4.65 | 0.00 |
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3 | 749.88 | 550.92 | 212.81 | 74.30 | 6.30 |
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4 | 195.87 | 74.58 | 37.64 | 6.97 | 0.00 |
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5 | 410.92 | 119.21 | 45.90 | 14.17 | 2.77 |
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1 | 300.75 | 112.32 | 26.08 | 15.44 | 0.53 |
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1 | 164.42 | 101.78 | 42.63 | 4.35 | 2.61 |
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6 | 287.07 | 89.88 | 41.51 | 11.68 | 1.30 |
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2 | 173.04 | 75.71 | 25.62 | 12.17 | 1.29 |
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1 | 190.92 | 77.04 | 42.05 | 4.09 | 0.37 |
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1 | 375.54 | 139.52 | 55.68 | 15.19 | 3.48 |
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5 | 305.01 | 84.26 | 47.09 | 8.58 | 1.91 |
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9 | 98.52 | 84.96 | 35.06 | 3.84 | 0.00 |
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8 | 318.39 | 107.41 | 42.79 | 5.99 | 1.28 |
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7 | 284.47 | 110.42 | 44.23 | 11.46 | 0.95 |
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3 | 146.00 | 83.99 | 27.47 | 7.06 | 2.35 |
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6 | 155.23 | 71.41 | 31.48 | 5.58 | 0.90 |
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6 | 147.70 | 59.03 | 37.89 | 4.39 | 0.55 |
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1 | 152.80 | 58.32 | 34.87 | 3.30 | 0.59 |
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8 | 313.99 | 103.72 | 32.35 | 13.95 | 1.01 |
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4 | 180.70 | 60.23 | 28.53 | 7.93 | 0.00 |
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4 | 209.79 | 110.37 | 38.76 | 12.64 | 1.26 |
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5 | 81.92 | 67.29 | 29.75 | 3.41 | 0.98 |
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5 | 935.62 | 260.77 | 98.95 | 32.17 | 5.61 |
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5 | 138.40 | 99.31 | 42.26 | 9.51 | 3.17 |
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6 | 112.61 | 98.14 | 43.00 | 7.92 | 2.59 |
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3 | 293.98 | 110.15 | 60.24 | 8.20 | 1.41 |
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6 | 457.68 | 128.83 | 59.89 | 18.08 | 1.13 |
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2 | 326.41 | 125.16 | 37.49 | 11.58 | 1.10 |
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7 | 662.78 | 189.74 | 56.39 | 20.57 | 2.65 |
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7 | 419.60 | 168.37 | 56.56 | 32.01 | 3.95 |
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1 | 129.07 | 102.44 | 37.04 | 7.52 | 1.74 |
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9 | 320.08 | 108.22 | 59.69 | 9.18 | 1.31 |
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3 | 253.23 | 68.99 | 31.45 | 9.74 | 0.81 |
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8 | 157.08 | 50.19 | 29.43 | 3.41 | 0.31 |
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8 | 103.66 | 55.21 | 25.63 | 3.10 | 1.69 |
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2 | 103.26 | 64.54 | 38.29 | 2.01 | 0.29 |
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1 | 181.66 | 88.82 | 47.65 | 4.13 | 0.59 |
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6 | 278.92 | 72.05 | 28.53 | 11.41 | 0.36 |
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8 | 130.91 | 58.18 | 19.16 | 4.26 | 1.42 |
Synoviocyte, donor2.CNhs11992.11368-117I9 | 1114.44 | 302.10 | 120.75 | 28.29 | 4.86 |
Synoviocyte, donor3.CNhs12050.11440-118H9 | 492.63 | 294.39 | 93.85 | 26.01 | 6.26 |
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2 | 59.96 | 51.61 | 20.49 | 1.90 | 0.00 |
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1 | 69.99 | 48.29 | 32.89 | 1.75 | 0.00 |
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5 | 182.53 | 70.72 | 26.56 | 6.64 | 1.44 |
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1 | 213.83 | 61.00 | 36.20 | 2.68 | 0.67 |
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1 | 91.47 | 58.80 | 33.76 | 6.53 | 0.00 |
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4 | 641.03 | 216.15 | 53.29 | 38.03 | 3.58 |
Urothelial Cells, donor1.CNhs11334.11520-119H8 | 265.62 | 141.21 | 42.62 | 11.62 | 0.00 |
Urothelial Cells, donor2.CNhs12091.11600-120H7 | 438.03 | 96.03 | 52.23 | 16.85 | 0.00 |
Urothelial Cells, donor3.CNhs12122.11681-122H7 | 374.26 | 162.74 | 58.53 | 12.86 | 1.33 |
Urothelial cells, donor0.CNhs10843.11216-116B1 | 390.30 | 139.67 | 51.46 | 13.78 | 0.46 |
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1 | 793.14 | 465.33 | 86.77 | 81.70 | 2.54 |
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2 | 782.99 | 423.61 | 78.76 | 78.76 | 5.35 |
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3 | 1750.53 | 436.35 | 96.84 | 66.65 | 7.98 |
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7 | 1020.35 | 283.50 | 64.80 | 45.26 | 9.77 |
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8 | 931.32 | 366.52 | 47.72 | 54.30 | 9.46 |
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4 | 791.14 | 432.53 | 84.95 | 89.49 | 3.24 |
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5 | 624.82 | 402.86 | 63.72 | 74.52 | 5.40 |
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6 | 1690.94 | 398.94 | 98.35 | 67.42 | 7.14 |
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8 | 84.18 | 45.08 | 27.35 | 3.85 | 0.53 |
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3 | 229.07 | 65.45 | 25.99 | 12.51 | 0.00 |
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6 | 326.39 | 100.22 | 40.43 | 12.50 | 1.47 |
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5 | 17.84 | 17.84 | 8.73 | 0.37 | 0.37 |
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3 | 64.49 | 35.20 | 21.78 | 1.30 | 0.72 |
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6 | 156.09 | 79.96 | 29.74 | 4.55 | 0.36 |
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5 | 98.84 | 56.92 | 23.28 | 3.51 | 1.91 |
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8 | 104.38 | 44.11 | 29.74 | 4.99 | 0.20 |
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6 | 211.23 | 102.46 | 55.54 | 6.70 | 2.87 |
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9 | 168.70 | 66.47 | 29.63 | 6.77 | 2.12 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5 | 103.23 | 69.79 | 33.11 | 2.27 | 1.30 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9 | 173.53 | 99.68 | 52.79 | 5.05 | 0.84 |
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9 | 68.24 | 34.46 | 19.17 | 1.60 | 1.14 |
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1 | 71.45 | 50.14 | 28.67 | 3.76 | 0.78 |
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2 | 95.24 | 52.63 | 42.61 | 7.52 | 2.51 |
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3 | 125.28 | 81.09 | 39.11 | 5.08 | 1.69 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4 | 54.44 | 37.90 | 17.83 | 1.61 | 0.64 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5 | 58.52 | 36.53 | 24.82 | 2.22 | 0.40 |
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8 | 116.68 | 58.34 | 29.81 | 3.41 | 0.85 |
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5 | 180.68 | 109.92 | 58.05 | 8.59 | 2.75 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3 | 105.38 | 55.92 | 21.81 | 3.69 | 1.23 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4 | 115.19 | 71.13 | 29.53 | 6.49 | 0.45 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9 | 107.45 | 67.91 | 32.54 | 6.67 | 0.33 |
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6 | 69.56 | 44.74 | 24.03 | 2.34 | 0.00 |
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7 | 79.35 | 34.52 | 20.05 | 3.62 | 0.00 |
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8 | 75.08 | 25.85 | 19.69 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9 | 51.66 | 23.26 | 12.17 | 0.81 | 0.00 |
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6 | 78.27 | 43.30 | 29.98 | 3.33 | 0.67 |
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1 | 60.62 | 23.97 | 5.64 | 0.00 | 0.00 |
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4 | 54.08 | 39.11 | 29.76 | 0.56 | 0.19 |
adipose tissue, adult, pool1.CNhs10615.10010-101C1 | 523.18 | 184.89 | 32.67 | 18.61 | 4.54 |
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9 | 81.19 | 39.44 | 41.38 | 2.18 | 0.97 |
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7 | 13.71 | 13.37 | 9.36 | 0.11 | 0.00 |
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6 | 47.45 | 32.68 | 19.04 | 0.85 | 0.00 |
amniotic membrane cells, donor1.CNhs12502.12235-129G3 | 699.28 | 284.11 | 66.13 | 78.31 | 6.45 |
amniotic membrane cells, donor2.CNhs12503.12236-129G4 | 563.94 | 199.86 | 79.29 | 12.77 | 4.45 |
amniotic membrane cells, donor3.CNhs12379.12237-129G5 | 142.22 | 172.01 | 57.75 | 7.37 | 9.83 |
amygdala - adult, donor10196.CNhs13793.10167-103B5 | 462.28 | 193.86 | 101.40 | 21.87 | 4.97 |
amygdala, adult, donor10252.CNhs12311.10151-102I7 | 387.68 | 172.74 | 54.86 | 16.04 | 5.63 |
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5 | 169.63 | 77.14 | 28.16 | 5.57 | 0.67 |
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3 | 32.96 | 14.67 | 7.09 | 1.32 | 0.66 |
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4 | 48.56 | 40.75 | 35.68 | 2.53 | 0.21 |
aorta, adult, pool1.CNhs11760.10052-101G7 | 713.31 | 246.67 | 85.88 | 19.53 | 5.98 |
appendix, adult.CNhs12842.10189-103D9 | 362.76 | 127.92 | 49.73 | 13.26 | 3.59 |
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4 | 131.76 | 74.82 | 37.79 | 4.03 | 0.50 |
astrocytoma cell line:TM-31.CNhs10742.10425-106D2 | 223.97 | 98.18 | 54.92 | 7.57 | 1.23 |
b cell line:RPMI1788.CNhs10744.10427-106D4 | 9.48 | 8.00 | 8.86 | 0.12 | 0.25 |
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9 | 311.35 | 120.68 | 41.37 | 14.93 | 4.98 |
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9 | 55.45 | 30.56 | 16.90 | 1.44 | 0.36 |
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1 | 137.31 | 53.35 | 16.47 | 9.31 | 1.43 |
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7 | 87.99 | 36.83 | 25.07 | 4.09 | 0.51 |
bladder, adult, pool1.CNhs10616.10011-101C2 | 630.33 | 199.06 | 52.77 | 19.24 | 4.93 |
blood, adult, pool1.CNhs11761.10053-101G8 | 1525.51 | 392.75 | 107.77 | 50.29 | 9.58 |
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2 | 212.27 | 121.14 | 55.57 | 4.45 | 2.22 |
brain, adult, donor1.CNhs11796.10084-102B3 | 543.80 | 173.51 | 104.69 | 33.93 | 11.63 |
brain, adult, pool1.CNhs10617.10012-101C3 | 539.54 | 223.01 | 98.98 | 23.66 | 3.15 |
brain, fetal, pool1.CNhs11797.10085-102B4 | 153.70 | 71.86 | 53.90 | 21.96 | 0.00 |
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5 | 152.61 | 55.73 | 23.70 | 7.55 | 2.08 |
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5 | 265.27 | 128.65 | 44.17 | 6.38 | 0.87 |
breast, adult, donor1.CNhs11792.10080-102A8 | 792.42 | 265.35 | 73.95 | 18.85 | 2.17 |
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4 | 359.47 | 249.32 | 51.66 | 25.15 | 2.62 |
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7 | 144.67 | 94.07 | 46.27 | 4.07 | 2.29 |
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8 | 60.04 | 27.42 | 10.64 | 1.42 | 0.71 |
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1 | 45.51 | 37.23 | 23.44 | 2.41 | 1.03 |
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8 | 42.57 | 23.91 | 13.12 | 0.58 | 0.29 |
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3 | 78.48 | 45.66 | 22.40 | 2.08 | 1.39 |
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6 | 510.19 | 198.41 | 73.52 | 22.14 | 2.66 |
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2 | 363.24 | 167.39 | 58.25 | 16.16 | 4.70 |
cerebellum - adult, donor10196.CNhs13799.10173-103C2 | 955.16 | 271.60 | 93.07 | 38.15 | 6.10 |
cerebellum, adult, donor10252.CNhs12323.10166-103B4 | 717.77 | 252.12 | 70.22 | 26.43 | 4.53 |
cerebellum, adult, pool1.CNhs11795.10083-102B2 | 691.29 | 214.27 | 93.10 | 36.35 | 12.71 |
cerebral meninges, adult.CNhs12840.10188-103D8 | 555.70 | 179.90 | 83.59 | 26.98 | 9.87 |
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3 | 89.98 | 46.41 | 14.71 | 2.83 | 0.22 |
cervical cancer cell line:ME-180.CNhs11289.10553-107I4 | 461.35 | 148.90 | 28.02 | 17.15 | 2.09 |
cervix, adult, pool1.CNhs10618.10013-101C4 | 711.64 | 261.02 | 67.87 | 27.32 | 4.85 |
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5 | 324.39 | 98.90 | 33.84 | 19.60 | 2.39 |
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6 | 63.41 | 23.75 | 23.29 | 2.08 | 0.69 |
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9 | 145.95 | 69.47 | 31.50 | 5.56 | 1.44 |
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2 | 274.33 | 92.68 | 32.05 | 8.58 | 1.74 |
chorionic membrane cells, donor1.CNhs12504.12238-129G6 | 2182.29 | 761.14 | 122.50 | 283.59 | 35.09 |
chorionic membrane cells, donor2.CNhs12506.12239-129G7 | 974.96 | 273.24 | 75.57 | 62.38 | 6.69 |
chorionic membrane cells, donor3.CNhs12380.12240-129G8 | 1331.52 | 890.70 | 127.40 | 333.15 | 66.63 |
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2 | 209.50 | 66.43 | 20.44 | 9.20 | 6.13 |
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9 | 138.46 | 55.10 | 30.45 | 4.24 | 0.94 |
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1 | 276.08 | 92.41 | 45.04 | 9.81 | 1.66 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5 | 23.01 | 17.15 | 12.86 | 0.45 | 0.23 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6 | 23.53 | 13.53 | 11.76 | 0.00 | 0.00 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7 | 30.21 | 17.29 | 11.92 | 0.00 | 0.00 |
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4 | 22.77 | 20.87 | 9.49 | 0.76 | 0.19 |
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4 | 137.80 | 51.02 | 29.09 | 4.61 | 0.00 |
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8 | 101.70 | 67.73 | 45.15 | 2.11 | 2.95 |
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6 | 1546.30 | 653.26 | 48.97 | 235.87 | 16.49 |
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9 | 108.56 | 69.55 | 27.99 | 4.66 | 0.71 |
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6 | 1075.02 | 443.16 | 127.67 | 39.17 | 2.60 |
colon, adult, donor1.CNhs11794.10082-102B1 | 288.63 | 112.46 | 53.74 | 12.94 | 0.00 |
colon, adult, pool1.CNhs10619.10014-101C5 | 558.61 | 203.45 | 50.86 | 20.88 | 2.03 |
colon, fetal, donor1.CNhs11780.10070-101I7 | 489.44 | 287.18 | 122.21 | 13.44 | 8.55 |
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2 | 39.44 | 13.64 | 6.23 | 2.67 | 0.59 |
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3 | 28.67 | 17.79 | 8.16 | 2.35 | 0.25 |
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8 | 29.24 | 17.86 | 9.61 | 1.46 | 0.21 |
corpus callosum, adult, pool1.CNhs10649.10042-101F6 | 572.24 | 249.79 | 83.44 | 25.81 | 1.15 |
diaphragm, fetal, donor1.CNhs11779.10069-101I6 | 300.97 | 148.48 | 66.61 | 12.84 | 8.83 |
diencephalon, adult.CNhs12610.10193-103E4 | 567.39 | 240.12 | 94.41 | 28.81 | 5.15 |
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1 | 23.90 | 22.44 | 11.49 | 0.55 | 0.36 |
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6 | 137.75 | 83.94 | 22.89 | 2.35 | 0.00 |
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2 | 43.94 | 31.80 | 13.11 | 1.21 | 0.49 |
ductus deferens, adult.CNhs12846.10196-103E7 | 972.26 | 246.22 | 71.81 | 28.80 | 6.31 |
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8 | 556.56 | 191.17 | 75.01 | 13.31 | 6.05 |
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9 | 104.68 | 65.50 | 37.65 | 2.75 | 2.75 |
dura mater, adult, donor1.CNhs10648.10041-101F5 | 680.52 | 189.62 | 59.21 | 31.66 | 1.64 |
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1 | 47.95 | 13.98 | 3.76 | 3.61 | 0.60 |
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9 | 72.17 | 24.47 | 9.02 | 3.73 | 0.52 |
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1 | 133.60 | 75.77 | 67.13 | 5.32 | 1.33 |
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2 | 72.82 | 58.25 | 39.06 | 3.31 | 0.33 |
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3 | 107.05 | 64.04 | 42.38 | 2.83 | 0.63 |
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9 | 95.58 | 75.27 | 52.57 | 4.78 | 1.19 |
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2 | 222.28 | 92.78 | 19.64 | 3.98 | 1.14 |
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7 | 123.98 | 61.99 | 33.28 | 7.49 | 2.63 |
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4 | 224.59 | 109.34 | 30.37 | 10.93 | 1.39 |
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3 | 246.25 | 88.10 | 26.07 | 7.55 | 0.20 |
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8 | 52.93 | 26.73 | 14.89 | 1.92 | 0.09 |
epididymis, adult.CNhs12847.10197-103E8 | 1899.80 | 555.28 | 87.71 | 129.30 | 10.83 |
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2 | 29.58 | 28.72 | 18.23 | 1.03 | 0.86 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5 | 46.44 | 39.38 | 13.45 | 2.42 | 0.39 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6 | 51.67 | 36.91 | 13.67 | 1.90 | 0.37 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7 | 53.05 | 38.18 | 15.19 | 1.64 | 0.33 |
esophagus, adult, pool1.CNhs10620.10015-101C6 | 639.74 | 206.10 | 49.27 | 24.54 | 2.42 |
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5 | 96.99 | 60.54 | 41.83 | 4.41 | 0.26 |
eye, fetal, donor1.CNhs11762.10054-101G9 | 704.16 | 226.21 | 82.26 | 21.69 | 3.16 |
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2 | 118.68 | 55.50 | 40.84 | 2.19 | 0.96 |
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9 | 52.26 | 22.26 | 17.69 | 1.39 | 0.60 |
frontal lobe, adult, pool1.CNhs10647.10040-101F4 | 423.23 | 186.13 | 82.68 | 22.10 | 1.20 |
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2 | 171.69 | 89.95 | 26.20 | 7.04 | 4.50 |
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1 | 149.26 | 107.33 | 59.56 | 6.17 | 0.64 |
gall bladder, adult.CNhs12848.10198-103E9 | 607.27 | 185.92 | 62.54 | 23.48 | 1.92 |
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2 | 214.40 | 80.72 | 24.58 | 5.39 | 1.20 |
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9 | 87.46 | 61.38 | 32.13 | 3.17 | 1.01 |
gastric cancer cell line:AZ521.CNhs11286.10549-107H9 | 821.23 | 313.26 | 57.61 | 92.09 | 3.09 |
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3 | 142.25 | 36.21 | 8.41 | 3.60 | 1.03 |
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1 | 26.65 | 26.79 | 7.92 | 1.01 | 0.29 |
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1 | 94.18 | 63.62 | 39.39 | 1.62 | 0.25 |
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4 | 320.54 | 113.13 | 41.72 | 9.43 | 2.36 |
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3 | 111.71 | 57.62 | 25.41 | 5.16 | 0.82 |
glioblastoma cell line:A172.CNhs11185.10444-106F3 | 134.94 | 48.85 | 21.97 | 4.50 | 0.84 |
glioblastoma cell line:T98G.CNhs11272.10485-107A8 | 154.02 | 69.77 | 28.05 | 3.67 | 0.82 |
glioma cell line:GI-1.CNhs10731.10413-106B8 | 70.79 | 31.21 | 20.80 | 3.18 | 0.58 |
globus pallidus - adult, donor10196.CNhs13801.10175-103C4 | 520.56 | 174.72 | 64.24 | 22.22 | 7.21 |
globus pallidus, adult, donor10252.CNhs12319.10161-103A8 | 382.79 | 182.49 | 47.78 | 12.32 | 4.93 |
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7 | 140.52 | 90.70 | 43.43 | 2.55 | 0.00 |
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3 | 347.25 | 121.19 | 52.00 | 9.45 | 4.30 |
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1 | 14.98 | 11.04 | 11.83 | 0.53 | 0.53 |
heart - mitral valve, adult.CNhs12855.10205-103F7 | 1141.71 | 270.35 | 71.50 | 42.73 | 8.66 |
heart - pulmonic valve, adult.CNhs12856.10206-103F8 | 547.01 | 185.16 | 55.23 | 21.08 | 6.87 |
heart - tricuspid valve, adult.CNhs12857.10207-103F9 | 628.14 | 150.75 | 38.77 | 21.54 | 6.46 |
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5 | 439.89 | 147.56 | 64.10 | 16.17 | 3.00 |
heart, adult, diseased, donor1.CNhs11758.10051-101G6 | 676.46 | 260.97 | 57.52 | 21.46 | 3.00 |
heart, adult, pool1.CNhs10621.10016-101C7 | 954.95 | 298.60 | 71.19 | 31.91 | 2.68 |
heart, fetal, pool1.CNhs10653.10046-101G1 | 268.33 | 158.96 | 63.89 | 9.47 | 0.94 |
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4 | 902.55 | 219.06 | 95.84 | 25.94 | 5.76 |
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3 | 187.56 | 47.76 | 15.14 | 8.15 | 0.00 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8 | 102.58 | 50.74 | 19.85 | 4.33 | 1.10 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9 | 103.18 | 46.73 | 19.53 | 3.87 | 0.49 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1 | 110.14 | 52.78 | 19.75 | 4.58 | 0.27 |
hepatoma cell line:Li-7.CNhs11271.10484-107A7 | 52.26 | 23.92 | 7.28 | 0.98 | 0.00 |
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hippocampus - adult, donor10196.CNhs13795.10169-103B7 | 617.89 | 197.22 | 82.70 | 34.99 | 9.54 |
hippocampus, adult, donor10252.CNhs12312.10153-102I9 | 430.95 | 203.90 | 59.52 | 14.98 | 8.04 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5 | 142.75 | 61.09 | 33.44 | 5.79 | 1.77 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4 | 124.89 | 43.74 | 31.36 | 4.54 | 1.38 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8 | 98.87 | 43.62 | 27.00 | 2.49 | 5.82 |
immature langerhans cells, donor1.CNhs13537.11904-125F5 | 432.40 | 114.06 | 67.27 | 27.22 | 2.70 |
immature langerhans cells, donor2.CNhs13480.11905-125F6 | 385.35 | 84.34 | 72.74 | 36.37 | 3.10 |
insula, adult, pool1.CNhs10646.10039-101F3 | 394.99 | 181.70 | 69.62 | 21.44 | 1.09 |
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8 | 945.93 | 223.06 | 64.07 | 23.82 | 4.36 |
kidney, adult, pool1.CNhs10622.10017-101C8 | 1691.72 | 517.44 | 88.42 | 105.28 | 8.43 |
kidney, fetal, pool1.CNhs10652.10045-101F9 | 841.95 | 362.30 | 88.33 | 47.47 | 2.10 |
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5 | 68.01 | 61.78 | 33.48 | 2.22 | 0.32 |
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2 | 129.27 | 65.44 | 52.17 | 2.51 | 1.43 |
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8 | 72.93 | 36.85 | 12.28 | 2.88 | 0.38 |
left atrium, adult, donor1.CNhs11790.10079-102A7 | 1019.87 | 254.43 | 92.20 | 20.73 | 10.72 |
left ventricle, adult, donor1.CNhs11789.10078-102A6 | 945.47 | 328.40 | 76.14 | 43.70 | 8.61 |
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1 | 80.35 | 33.31 | 30.77 | 1.78 | 0.76 |
leiomyoma cell line:10964C.CNhs11722.10569-108B2 | 520.19 | 184.08 | 56.47 | 39.64 | 5.43 |
leiomyoma cell line:15242A.CNhs11723.10570-108B3 | 418.28 | 180.62 | 57.90 | 27.66 | 7.78 |
leiomyoma cell line:15425.CNhs11724.10571-108B4 | 320.38 | 144.03 | 46.38 | 17.64 | 2.29 |
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8 | 170.02 | 44.30 | 17.96 | 3.59 | 1.20 |
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5 | 150.31 | 45.73 | 21.02 | 3.69 | 0.41 |
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8 | 410.29 | 119.95 | 68.67 | 11.76 | 2.90 |
liposarcoma cell line:SW 872.CNhs11851.10726-110A6 | 376.88 | 122.38 | 54.16 | 8.39 | 2.49 |
liver, adult, pool1.CNhs10624.10018-101C9 | 506.34 | 146.99 | 40.59 | 16.27 | 1.91 |
liver, fetal, pool1.CNhs11798.10086-102B5 | 443.90 | 128.53 | 71.55 | 10.60 | 2.65 |
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2 | 517.91 | 175.95 | 70.72 | 20.69 | 9.83 |
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3 | 445.36 | 202.58 | 60.69 | 19.70 | 5.55 |
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4 | 85.03 | 53.72 | 30.62 | 4.45 | 0.51 |
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3 | 155.06 | 93.04 | 40.17 | 2.11 | 0.00 |
lung, adult, pool1.CNhs10625.10019-101D1 | 976.25 | 310.32 | 75.18 | 35.45 | 5.13 |
lung, fetal, donor1.CNhs11680.10068-101I5 | 241.47 | 272.59 | 49.99 | 33.33 | 1.89 |
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3 | 992.52 | 332.22 | 103.97 | 38.52 | 9.53 |
lymph node, adult, donor1.CNhs11788.10077-102A5 | 693.64 | 214.84 | 112.63 | 27.79 | 3.97 |
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7 | 185.56 | 88.53 | 66.40 | 2.77 | 1.38 |
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1 | 34.95 | 26.92 | 13.64 | 0.85 | 0.12 |
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7 | 269.38 | 63.83 | 12.13 | 7.02 | 1.28 |
mature adipocyte, donor1.CNhs12558.12231-129F8 | 839.42 | 210.53 | 30.46 | 34.27 | 2.72 |
mature adipocyte, donor2.CNhs12559.12232-129F9 | 623.47 | 186.76 | 27.83 | 27.83 | 2.01 |
mature adipocyte, donor3.CNhs12560.12233-129G1 | 772.91 | 201.88 | 28.80 | 39.52 | 2.45 |
mature adipocyte, donor4.CNhs12562.12234-129G2 | 564.60 | 161.97 | 31.80 | 38.69 | 2.30 |
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9 | 78.21 | 31.57 | 19.16 | 3.14 | 0.00 |
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8 | 377.47 | 142.66 | 78.86 | 18.61 | 8.86 |
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3 | 379.38 | 126.42 | 64.06 | 15.74 | 7.69 |
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6 | 379.20 | 171.01 | 55.58 | 16.15 | 3.00 |
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3 | 700.71 | 202.99 | 71.10 | 26.95 | 6.88 |
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2 | 546.21 | 235.39 | 68.55 | 21.96 | 3.99 |
medulla oblongata, adult, pool1.CNhs10645.10038-101F2 | 572.65 | 242.55 | 80.79 | 28.25 | 1.12 |
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1 | 350.85 | 98.50 | 37.91 | 7.75 | 1.11 |
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3 | 200.09 | 76.24 | 37.49 | 3.87 | 0.87 |
melanoma cell line:COLO 679.CNhs11281.10514-107E1 | 73.85 | 49.44 | 28.36 | 1.21 | 0.30 |
melanoma cell line:G-361.CNhs11254.10465-106H6 | 77.65 | 47.10 | 26.55 | 5.99 | 2.85 |
meningioma cell line:HKBMM.CNhs11945.10691-109F7 | 130.34 | 84.70 | 44.47 | 4.00 | 0.47 |
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6 | 55.73 | 34.19 | 16.39 | 0.94 | 1.87 |
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7 | 66.81 | 28.40 | 18.26 | 2.46 | 0.87 |
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1 | 147.17 | 91.49 | 42.24 | 9.70 | 0.90 |
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2 | 122.23 | 77.83 | 32.25 | 8.65 | 1.17 |
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3 | 160.89 | 104.30 | 29.96 | 12.76 | 3.33 |
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4 | 143.38 | 116.67 | 67.05 | 7.77 | 1.14 |
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5 | 237.48 | 156.48 | 61.38 | 13.33 | 4.03 |
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4 | 1072.22 | 289.19 | 109.45 | 32.03 | 8.01 |
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6 | 416.95 | 201.61 | 73.00 | 25.86 | 2.75 |
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7 | 266.92 | 163.78 | 58.38 | 20.72 | 3.18 |
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8 | 173.31 | 115.96 | 46.94 | 11.81 | 0.93 |
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9 | 196.50 | 124.79 | 63.13 | 13.31 | 1.92 |
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1 | 158.50 | 100.36 | 50.02 | 13.54 | 2.55 |
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6 | 428.21 | 122.80 | 67.02 | 17.99 | 3.60 |
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5 | 164.58 | 108.06 | 47.98 | 9.78 | 1.86 |
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9 | 371.99 | 131.46 | 63.45 | 11.20 | 2.90 |
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3 | 203.10 | 149.93 | 73.11 | 14.89 | 4.25 |
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8 | 357.92 | 136.70 | 56.35 | 12.00 | 3.65 |
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7 | 182.71 | 169.79 | 84.29 | 11.57 | 2.40 |
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2 | 431.07 | 121.10 | 54.46 | 17.90 | 3.05 |
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2 | 106.60 | 93.17 | 45.16 | 9.76 | 3.25 |
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4 | 173.12 | 107.84 | 57.65 | 9.64 | 2.18 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6 | 170.57 | 111.92 | 54.24 | 13.21 | 2.15 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6 | 314.61 | 147.56 | 78.42 | 9.28 | 2.32 |
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1 | 436.71 | 133.36 | 49.36 | 17.12 | 3.58 |
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1 | 83.61 | 54.00 | 28.40 | 2.00 | 1.20 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8 | 353.70 | 128.77 | 50.48 | 12.02 | 2.40 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9 | 355.61 | 149.18 | 62.97 | 12.46 | 3.03 |
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3 | 581.71 | 181.71 | 75.71 | 20.19 | 1.26 |
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7 | 70.69 | 50.27 | 35.06 | 1.73 | 0.77 |
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8 | 106.79 | 60.90 | 11.79 | 4.07 | 0.43 |
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4 | 52.20 | 30.01 | 7.57 | 1.57 | 0.00 |
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5 | 105.42 | 54.86 | 19.72 | 3.40 | 0.91 |
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6 | 76.17 | 33.11 | 16.90 | 3.70 | 1.16 |
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7 | 157.12 | 71.71 | 24.72 | 8.08 | 0.98 |
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8 | 102.80 | 51.94 | 26.15 | 3.22 | 0.72 |
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9 | 142.05 | 84.61 | 37.67 | 4.63 | 1.24 |
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1 | 142.32 | 62.93 | 35.30 | 3.73 | 0.88 |
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1 | 65.37 | 27.92 | 13.78 | 2.65 | 1.06 |
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9 | 118.84 | 51.89 | 24.11 | 5.02 | 1.35 |
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2 | 158.13 | 71.12 | 25.68 | 6.25 | 1.69 |
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8 | 912.73 | 223.70 | 59.45 | 69.19 | 7.17 |
mesothelioma cell line:No36.CNhs13074.10857-111G2 | 68.74 | 39.38 | 12.78 | 1.73 | 0.69 |
mesothelioma cell line:ONE58.CNhs13075.10858-111G3 | 140.69 | 61.38 | 19.75 | 3.04 | 1.22 |
middle temporal gyrus, donor10252.CNhs12316.10156-103A3 | 368.74 | 168.26 | 48.11 | 13.55 | 6.91 |
migratory langerhans cells, donor1.CNhs13535.11901-125F2 | 290.73 | 127.05 | 40.34 | 11.69 | 2.14 |
migratory langerhans cells, donor2.CNhs13536.11902-125F3 | 223.88 | 111.87 | 37.73 | 10.10 | 1.46 |
migratory langerhans cells, donor3.CNhs13547.11903-125F4 | 342.67 | 152.61 | 39.58 | 14.07 | 1.64 |
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5 | 150.05 | 59.95 | 26.54 | 5.90 | 3.93 |
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9 | 264.21 | 105.44 | 44.73 | 6.39 | 3.69 |
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1 | 88.96 | 39.52 | 18.81 | 2.32 | 0.42 |
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6 | 56.60 | 36.80 | 28.60 | 2.00 | 0.60 |
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7 | 130.27 | 54.31 | 19.52 | 6.93 | 0.53 |
myeloma cell line:PCM6.CNhs11258.10474-106I6 | 35.82 | 25.49 | 9.99 | 1.38 | 0.00 |
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6 | 62.99 | 39.73 | 26.67 | 1.70 | 0.57 |
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9 | 82.48 | 49.34 | 34.06 | 2.21 | 0.74 |
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3 | 157.78 | 78.19 | 30.35 | 7.55 | 0.56 |
nasal epithelial cells, donor2.CNhs12574.12227-129F4 | 248.21 | 91.45 | 35.46 | 12.44 | 1.24 |
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4 | 41.18 | 24.43 | 15.48 | 1.79 | 0.00 |
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8 | 147.18 | 75.91 | 33.32 | 5.18 | 0.65 |
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4 | 94.83 | 58.97 | 33.34 | 3.15 | 0.63 |
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6 | 98.40 | 58.10 | 26.65 | 3.06 | 0.87 |
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9 | 59.92 | 19.86 | 14.09 | 0.34 | 0.17 |
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7 | 73.98 | 36.35 | 21.68 | 2.13 | 1.49 |
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6 | 247.62 | 65.19 | 26.89 | 4.96 | 1.36 |
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8 | 78.77 | 39.11 | 26.81 | 0.00 | 0.56 |
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9 | 219.10 | 83.64 | 35.62 | 3.50 | 1.27 |
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7 | 120.11 | 85.72 | 40.14 | 2.92 | 0.24 |
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1 | 136.90 | 52.04 | 27.22 | 10.41 | 0.00 |
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3 | 348.09 | 139.31 | 68.42 | 12.34 | 10.58 |
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2 | 304.71 | 122.50 | 41.96 | 9.80 | 3.37 |
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1 | 374.78 | 186.26 | 76.75 | 22.42 | 0.83 |
occipital cortex - adult, donor10196.CNhs13798.10172-103C1 | 395.33 | 153.03 | 69.43 | 22.67 | 1.42 |
occipital cortex, adult, donor10252.CNhs12320.10163-103B1 | 327.57 | 156.28 | 46.77 | 11.33 | 7.34 |
occipital lobe, adult, donor1.CNhs11787.10076-102A4 | 456.38 | 213.12 | 120.40 | 24.41 | 8.41 |
occipital lobe, fetal, donor1.CNhs11784.10073-102A1 | 84.70 | 45.12 | 37.31 | 2.77 | 1.76 |
occipital pole, adult, pool1.CNhs10643.10036-101E9 | 410.17 | 216.12 | 98.06 | 23.79 | 1.11 |
olfactory region, adult.CNhs12611.10195-103E6 | 427.75 | 190.86 | 81.38 | 17.92 | 3.88 |
optic nerve, donor1.CNhs13449.10277-104E7 | 649.60 | 291.25 | 109.93 | 32.84 | 7.14 |
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2 | 311.52 | 61.83 | 18.45 | 10.89 | 0.88 |
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1 | 448.17 | 218.60 | 57.57 | 26.31 | 1.89 |
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5 | 572.66 | 169.49 | 42.92 | 20.54 | 3.49 |
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4 | 125.69 | 93.69 | 60.54 | 4.27 | 0.69 |
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2 | 260.48 | 98.78 | 57.21 | 8.39 | 4.58 |
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6 | 69.73 | 40.04 | 20.02 | 4.14 | 1.38 |
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9 | 94.88 | 47.94 | 24.47 | 3.18 | 0.40 |
ovary, adult, pool1.CNhs10626.10020-101D2 | 788.58 | 322.88 | 75.21 | 26.70 | 2.18 |
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3 | 181.53 | 59.30 | 30.46 | 4.24 | 2.42 |
pancreas, adult, donor1.CNhs11756.10049-101G4 | 310.26 | 146.92 | 51.58 | 11.72 | 0.78 |
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5 | 169.98 | 66.79 | 42.43 | 7.33 | 1.31 |
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5 | 168.19 | 59.12 | 19.82 | 4.26 | 0.98 |
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3 | 91.38 | 63.87 | 26.76 | 2.37 | 0.44 |
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8 | 407.18 | 202.95 | 88.00 | 24.58 | 1.08 |
parietal lobe - adult, donor10196.CNhs13797.10171-103B9 | 406.16 | 149.97 | 67.17 | 21.09 | 3.91 |
parietal lobe, adult, donor10252.CNhs12317.10157-103A4 | 297.42 | 173.82 | 45.47 | 14.26 | 3.51 |
parietal lobe, adult, pool1.CNhs10641.10034-101E7 | 402.06 | 188.98 | 82.31 | 20.36 | 0.76 |
parietal lobe, fetal, donor1.CNhs11782.10072-101I9 | 78.22 | 48.13 | 33.37 | 3.28 | 2.19 |
parotid gland, adult.CNhs12849.10199-103F1 | 551.55 | 199.02 | 78.40 | 18.64 | 2.74 |
penis, adult.CNhs12850.10200-103F2 | 608.85 | 186.08 | 50.12 | 14.39 | 12.41 |
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4 | 134.01 | 41.86 | 9.32 | 8.97 | 0.18 |
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3 | 462.63 | 144.63 | 59.92 | 13.03 | 2.68 |
pineal gland - adult, donor10196.CNhs13804.10179-103C8 | 643.91 | 202.50 | 106.60 | 22.50 | 13.93 |
pineal gland, adult, donor10252.CNhs12228.10160-103A7 | 392.78 | 156.71 | 69.61 | 14.80 | 3.36 |
pituitary gland - adult, donor10196.CNhs13805.10180-103C9 | 682.23 | 217.29 | 112.90 | 18.21 | 4.86 |
pituitary gland, adult, donor10252.CNhs12229.10162-103A9 | 530.45 | 259.53 | 91.98 | 23.90 | 3.87 |
placenta, adult, pool1.CNhs10627.10021-101D3 | 1109.76 | 382.31 | 70.96 | 117.71 | 4.97 |
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3 | 29.27 | 23.39 | 26.04 | 1.04 | 0.35 |
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4 | 885.91 | 214.02 | 47.33 | 27.78 | 6.00 |
pons, adult, pool1.CNhs10640.10033-101E6 | 433.85 | 196.57 | 76.87 | 20.93 | 1.09 |
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5 | 442.78 | 191.14 | 86.36 | 22.89 | 1.12 |
prostate cancer cell line:DU145.CNhs11260.10490-107B4 | 50.00 | 39.12 | 27.18 | 1.89 | 0.59 |
prostate cancer cell line:PC-3.CNhs11243.10439-106E7 | 44.72 | 30.03 | 17.57 | 1.33 | 0.78 |
prostate, adult, pool1.CNhs10628.10022-101D4 | 638.15 | 256.52 | 68.52 | 20.41 | 3.22 |
putamen, adult, donor10196.CNhs12324.10176-103C5 | 327.90 | 167.49 | 64.26 | 15.24 | 2.36 |
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1 | 125.84 | 79.04 | 24.94 | 3.92 | 1.12 |
rectum, fetal, donor1.CNhs11777.10067-101I4 | 212.77 | 106.84 | 60.27 | 7.31 | 5.48 |
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6 | 818.80 | 265.59 | 55.49 | 44.27 | 3.67 |
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3 | 213.56 | 168.65 | 49.21 | 4.30 | 4.30 |
retina, adult, pool1.CNhs10636.10030-101E3 | 853.14 | 262.46 | 82.56 | 32.52 | 2.64 |
retinoblastoma cell line:Y79.CNhs11267.10475-106I7 | 57.52 | 39.19 | 20.86 | 4.90 | 0.79 |
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4 | 1605.18 | 488.45 | 89.51 | 135.54 | 12.09 |
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9 | 29.21 | 22.95 | 10.95 | 0.70 | 0.17 |
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2 | 318.28 | 109.03 | 55.32 | 3.21 | 2.41 |
salivary acinar cells, donor1.CNhs12810.11771-123I7 | 610.46 | 153.13 | 56.78 | 24.24 | 4.77 |
salivary acinar cells, donor2.CNhs12811.11772-123I8 | 776.60 | 191.72 | 66.92 | 30.73 | 3.07 |
salivary acinar cells, donor3.CNhs12812.11773-123I9 | 991.96 | 220.51 | 64.29 | 36.64 | 4.84 |
salivary gland, adult, pool1.CNhs11677.10093-102C3 | 294.28 | 251.68 | 50.77 | 20.22 | 1.29 |
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1 | 44.37 | 36.45 | 20.47 | 1.89 | 0.95 |
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1 | 55.90 | 35.02 | 18.49 | 1.96 | 0.26 |
seminal vesicle, adult.CNhs12851.10201-103F3 | 989.46 | 316.69 | 77.06 | 33.87 | 9.74 |
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9 | 237.13 | 111.80 | 32.07 | 8.71 | 0.69 |
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7 | 468.41 | 205.98 | 78.17 | 15.20 | 4.96 |
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5 | 284.75 | 161.49 | 58.29 | 8.60 | 3.82 |
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9 | 678.52 | 250.67 | 51.34 | 37.25 | 3.36 |
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4 | 90.69 | 49.27 | 26.30 | 2.45 | 0.59 |
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6 | 330.03 | 135.94 | 29.38 | 18.29 | 0.49 |
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3 | 162.50 | 67.33 | 23.95 | 4.53 | 3.88 |
skeletal muscle, adult, pool1.CNhs10629.10023-101D5 | 270.00 | 127.30 | 31.62 | 9.75 | 1.64 |
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3 | 250.52 | 81.19 | 39.43 | 2.32 | 3.48 |
skin, fetal, donor1.CNhs11774.10065-101I2 | 288.51 | 99.57 | 43.23 | 7.29 | 5.34 |
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8 | 114.16 | 64.80 | 47.72 | 2.34 | 1.17 |
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7 | 53.32 | 25.66 | 12.53 | 1.99 | 0.40 |
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4 | 65.05 | 37.10 | 34.37 | 3.33 | 0.95 |
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1 | 83.69 | 43.26 | 20.10 | 5.31 | 0.11 |
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5 | 55.08 | 55.30 | 36.06 | 1.98 | 0.55 |
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4 | 43.48 | 29.29 | 18.12 | 1.36 | 0.91 |
small intestine, adult, pool1.CNhs10630.10024-101D6 | 791.50 | 234.46 | 53.17 | 24.70 | 3.63 |
small intestine, fetal, donor1.CNhs11773.10064-101I1 | 622.68 | 196.92 | 65.13 | 16.83 | 4.15 |
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6 | 85.60 | 65.37 | 20.69 | 3.29 | 0.94 |
smooth muscle, adult, pool1.CNhs11755.10048-101G3 | 525.84 | 152.97 | 38.98 | 16.42 | 2.45 |
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7 | 128.21 | 45.72 | 19.80 | 2.36 | 0.47 |
spinal cord - adult, donor10196.CNhs13807.10181-103D1 | 724.77 | 193.17 | 78.33 | 25.52 | 9.82 |
spinal cord, adult, donor10252.CNhs12227.10159-103A6 | 670.43 | 260.81 | 63.86 | 28.81 | 4.46 |
spinal cord, fetal, donor1.CNhs11764.10056-101H2 | 493.66 | 184.70 | 90.45 | 11.83 | 9.72 |
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8 | 294.82 | 87.85 | 54.04 | 7.99 | 1.70 |
spleen, adult, pool1.CNhs10631.10025-101D7 | 613.15 | 207.23 | 57.89 | 20.02 | 2.73 |
spleen, fetal, pool1.CNhs10651.10044-101F8 | 421.62 | 164.88 | 55.30 | 21.59 | 0.90 |
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1 | 10.29 | 8.20 | 6.40 | 0.40 | 0.20 |
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4 | 79.46 | 47.32 | 13.93 | 2.14 | 1.07 |
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4 | 104.10 | 33.17 | 10.23 | 4.94 | 0.71 |
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9 | 42.85 | 33.46 | 10.43 | 1.52 | 0.24 |
stomach, fetal, donor1.CNhs11771.10062-101H8 | 503.93 | 142.42 | 66.46 | 15.34 | 1.46 |
submaxillary gland, adult.CNhs12852.10202-103F4 | 586.26 | 181.20 | 63.30 | 12.84 | 2.29 |
substantia nigra, adult, donor10252.CNhs12318.10158-103A5 | 475.60 | 237.37 | 63.50 | 19.92 | 5.45 |
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9 | 100.18 | 57.74 | 25.87 | 2.68 | 2.21 |
temporal lobe, adult, pool1.CNhs10637.10031-101E4 | 426.17 | 195.95 | 88.66 | 22.30 | 1.50 |
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9 | 116.94 | 58.91 | 37.96 | 4.36 | 1.31 |
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8 | 433.80 | 192.57 | 51.32 | 14.28 | 8.99 |
tenocyte, donor1.CNhs12639.11763-123H8 | 442.30 | 217.62 | 98.58 | 17.86 | 2.23 |
tenocyte, donor2.CNhs12640.11765-123I1 | 793.56 | 268.06 | 120.63 | 18.49 | 7.86 |
tenocyte, donor3.CNhs12641.11768-123I4 | 381.58 | 207.66 | 77.87 | 21.20 | 4.33 |
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6 | 312.64 | 103.46 | 54.63 | 5.55 | 3.91 |
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7 | 173.19 | 55.40 | 26.88 | 5.46 | 1.20 |
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6 | 83.75 | 39.78 | 29.90 | 1.27 | 1.01 |
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3 | 710.66 | 193.68 | 53.14 | 26.62 | 2.96 |
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6 | 495.96 | 168.08 | 54.78 | 17.37 | 2.14 |
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8 | 202.81 | 150.25 | 36.76 | 19.76 | 0.83 |
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5 | 376.06 | 174.74 | 48.14 | 19.05 | 3.76 |
testis, adult, pool1.CNhs10632.10026-101D8 | 598.65 | 203.69 | 57.67 | 20.38 | 5.61 |
testis, adult, pool2.CNhs12998.10096-102C6 | 207.94 | 88.16 | 32.96 | 17.42 | 1.34 |
thalamus - adult, donor10196.CNhs13794.10168-103B6 | 576.27 | 218.07 | 73.80 | 18.24 | 8.29 |
thalamus, adult, donor10252.CNhs12314.10154-103A1 | 427.59 | 215.45 | 56.27 | 18.00 | 5.69 |
throat, adult.CNhs12858.10209-103G2 | 502.38 | 163.12 | 47.98 | 17.27 | 4.48 |
throat, fetal, donor1.CNhs11770.10061-101H7 | 383.52 | 149.98 | 73.09 | 12.62 | 5.71 |
thymus, adult, pool1.CNhs10633.10027-101D9 | 219.21 | 125.75 | 61.49 | 8.01 | 1.36 |
thymus, fetal, pool1.CNhs10650.10043-101F7 | 241.91 | 113.41 | 53.82 | 8.44 | 1.24 |
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9 | 104.51 | 47.21 | 21.42 | 2.13 | 1.23 |
thyroid, adult, pool1.CNhs10634.10028-101E1 | 528.08 | 295.96 | 108.58 | 17.50 | 2.42 |
thyroid, fetal, donor1.CNhs11769.10060-101H6 | 501.65 | 200.70 | 93.58 | 12.33 | 6.06 |
tongue, adult.CNhs12853.10203-103F5 | 611.13 | 182.88 | 43.98 | 28.96 | 5.66 |
tongue, fetal, donor1.CNhs11768.10059-101H5 | 506.16 | 162.90 | 67.76 | 13.35 | 4.45 |
tonsil, adult, pool1.CNhs10654.10047-101G2 | 417.92 | 166.49 | 53.41 | 16.84 | 1.01 |
trachea, adult, pool1.CNhs10635.10029-101E2 | 498.25 | 198.03 | 61.75 | 19.08 | 1.58 |
trachea, fetal, donor1.CNhs11766.10058-101H4 | 500.99 | 184.96 | 85.83 | 16.63 | 5.66 |
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4 | 101.67 | 45.83 | 22.47 | 2.60 | 0.41 |
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6 | 67.56 | 41.62 | 19.74 | 2.56 | 0.64 |
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1 | 195.00 | 63.71 | 50.20 | 5.79 | 0.00 |
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5 | 126.29 | 52.82 | 32.61 | 2.52 | 0.63 |
umbilical cord, fetal, donor1.CNhs11765.10057-101H3 | 417.66 | 159.56 | 75.09 | 4.69 | 0.00 |
uterus, adult, pool1.CNhs11676.10100-102D1 | 285.92 | 221.87 | 42.54 | 27.50 | 2.57 |
uterus, fetal, donor1.CNhs11763.10055-101H1 | 615.23 | 202.23 | 82.60 | 23.19 | 7.73 |
vagina, adult.CNhs12854.10204-103F6 | 479.34 | 195.73 | 53.93 | 13.98 | 0.00 |
vein, adult.CNhs12844.10191-103E2 | 610.87 | 188.19 | 61.19 | 21.94 | 3.02 |
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5 | 13.46 | 13.14 | 16.35 | 0.32 | 0.32 |